The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Unrelated Double Umbilical Cord Blood Units Transplantation
Official Title: Evaluation of Benefit and Side Effects of Double Umbilical Cord Blood Units Stem Cell Transplantation in Hematologic Malignancies
Study ID: NCT01015742
Brief Summary: The purpose of this study is to determine the safety and feasibility of unrelated double umbilical cord blood units Transplantation in patients with haematological malignancies using Antithymocyte Globulin Cyclophosphamide, busulfan as conditioning and cyclosporin, methylprednisolone as GVHD prophylaxis.
Detailed Description:
Minimum Age: 1 Year
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Hematology-Oncology & SCT Research Center, Tehran, , Iran, Islamic Republic of
Name: Amir Ali Hamidieh, MD
Affiliation: Hematology-Oncology and SCT Research Center
Role: PRINCIPAL_INVESTIGATOR